Your session is about to expire
← Back to Search
Collaborative Care for Opioid Addiction and Mental Health (CHAMP Trial)
N/A
Waitlist Available
Led By John Fortney, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if a Collaborative Care model can treat opioid use disorder and mental health disorders together in primary care.
Who is the study for?
This trial is for individuals who use opioids and have mental health issues like depression, anxiety, or PTSD. They must show signs of opioid addiction and have experienced symptoms recently. It's not specified who can't join the trial.
What is being tested?
The study tests if Collaborative Care (CoCM) can treat both mental health disorders and opioid use disorder in primary care settings. One group gets CoCM for both conditions; the control group only for mental health. The outcomes will be compared using different trial designs.
What are the potential side effects?
Since this trial focuses on a care model rather than a specific medication, side effects are related to how effective the treatment is at managing patients' opioid use disorder and mental health conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Mental Health Functioning
Illicit Opioid Use
Secondary study objectives
Change in Anxiety Symptoms
Change in Depression Symptoms
Change in PTSD Symptoms
+1 moreOther study objectives
Change in Access to Addiction Care for Opioid Use Disorder
Risk factors for premature mortality
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative Care for Opioid Use DisorderExperimental Treatment2 Interventions
Collaborative Care Management is an integrated care model that operationalizes the principles of the chronic care model to improve access to evidence-based treatments for opioid use disorder.
Group II: Collaborative Care for Mental Health DisordersActive Control1 Intervention
Collaborative Care Management is an integrated care model that operationalizes the principles of the chronic care model to improve access to evidence-based treatments for mental health disorders.
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,809 Previous Clinical Trials
1,912,221 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,894 Previous Clinical Trials
2,730,565 Total Patients Enrolled
University of ArkansasOTHER
494 Previous Clinical Trials
149,347 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Collaborative Care for Mental Health Disorders
- Group 2: Collaborative Care for Opioid Use Disorder
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger